Plus, hydrocodone combination products and brodalumab
Search results for: juvenile idiopathic arthritis
Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease
A review of data on antinuclear antibodies and tests for rheumatoid arthritis
Ebola: Hemorrhagic Fever and Macrophage Activation Syndrome
Rheumatologists focus on similar clinical, laboratory findings to better
understand pathobiology of Ebola infection
The ACR/ARHP Member News
Awards, appointments and announcements in the world of rheumatology
Rheumatology Research Foundation’s Annual Investigators’ Meeting Spotlights Latest Findings
Groundbreaking research in treatments for rheumatoid arthritis, inflammatory disease discussed at Foundation’s celebrated event
Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
Rheumatology Drug Updates, Trials, Safety Data
An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid
Rheumatology Drug Updates, Trials, Safety Data
Information on oral anticoagulant apixaban, apremilast for active psoriatic arthritis, hyaluronic acid and methotrexate injections, and drug safety updates rheumatologists need to know
7 Things Ophthalmologists Want Rheumatologists to Know
Careful collaboration is key to treating patients with rheumatic or inflammatory diseases that affect the eyes
Recipients of Ephraim P. Engleman Endowed Resident Research Preceptorship Award in Rheumatology Meet Physician Who Helped Shape Their Careers
Award’s namesake, 103-year-old rheumatologist Ephraim P. Engleman, MD, met 10 winners of research funding established in his name by the Rheumatology Research Foundation in 2006
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 38
- Next Page »